Page 2 - Maureen Testoni News Today

The PROTECT 340B would block health insurers and pharmacy benefit managers from treating 340B pharmacies differently.

Healthcare

BioPharma

Pharmaceutical manufacturers got a victory from the Third Circuit Court of Appeals, with judges ruling providers could not use the 340B drug discount program.

Ambulatory surgery centers will receive a $230 million Medicare reimbursement boost next year under the Outpatient Prospective Payment System final rule. 

The American Hospital Association is calling the government's increase for outpatient care "insufficient" given extraordinary cost pressures. The Centers for Medicare and Medicaid Services is updating the 2023 Outpatient Prospective System and Ambulatory Surgical Center payment rates by 3.8% in the final rule released on Tuesday.

The Centers for Medicare and Medicaid Services released several final policies affecting sectors across the industry — and patients across the country.

The U.S. Department of Health and Human Services (HHS) must immediately halt 30 percent reimbursement cuts to hospitals ...

The Department of Health and Human Services must immediately stop the 30% drug reimbursement cuts to hospitals in the 340B program, a federal judge has ruled. The order from judge Rudolph Contreras with the U.S. District Court for the District of Columbia rejects HHS' plan to wait until January 1, 2023, to restore the full outpatient drug payment rates to 340B hospitals. The

Early data analyzed by the CDC shows that unvaccinated people at risk for monkeypox were 14 times more likely to be infected.